Saturday's attack is the biggest on Saudi oil infrastructure since Saddam Hussein's invasion of Kuwait in 1990.Energyread more
Saudi Aramco is aiming to restore by Monday about a third of its crude output that was disrupted after drone attacks on two key oil facilities, The Wall Street Journal...Marketsread more
"Blaming Iran won't end disaster. Accepting our April '15 proposal to end war & begin talks may," Zarif said on Twitter.Energyread more
Oil prices are expected to jump as much as $10 per barrel after a coordinated drone strike hit Saudi Arabia's largest oil field, forcing the kingdom to cut its oil output in...Marketsread more
Apple's new iPhones can still send texts, download apps, and make video calls, but the company spends a lot of time and effort marketing its new phones as powerful photography...Technologyread more
The trucking industry is worth hundreds of billions of dollars per year. Uber is going after this market with Uber Freight, an online platform that matches truckers with...Technologyread more
Some U.S. manufacturers say tariffs, if targeted, will help address longstanding unfair trade practices like intellectual property theft.Traderead more
Supporters of a $15 minimum wage ballot initiative in Florida argue the state's inflation-tied pay hikes have not gone far enough.2020 Electionsread more
Saudi Arabia shut down half its oil production Saturday after drone strikes hit the world's largest oil processing facility in an attack claimed by Yemen's Houthi rebels.Politicsread more
Trusii's hydrogen water machines were supposed to help users with their health problems, but customers claim the company is involved in a giant scam.Technologyread more
The decoupling of the world's two weightiest economies seems as inescapable as its extent and global impact remains incalculable.Politicsread more
AbbVie shares fell almost 3 percent on Tuesday after the California Department of Insurance sued the pharmaceutical company for allegedly giving health-care providers kickbacks for prescribing its arthritis drug Humira.
The suit alleges that AbbVie provided cash, trips and other gifts to health-care providers as incentives to prescribe the drug. The company allegedly also provided additional professional services, such as free insurance processing and marketing assistance.
The scheme was pulled off by a group of registered nurses known as Abbvie Nurse Ambassadors, who are sent into patients' homes after they are prescribed Humira and were trained to downplay potential risks of the drug, according to the suit.
The company "only provides the Ambassadors as long as the physicians continue to prescribe AbbVie's drug instead of selecting another course of treatment," according to the California Department of Insurance.
AbbVie spokeswoman Adelle Infante said in a statement that the allegations had no merit.
"AbbVie provides a number of support services for patients, once they are prescribed Humira, that both educate and assist patients with their therapy, including nursing support, and these resources are beneficial to patients dealing with a chronic condition," Infante said. "They in no way replace or interfere with interactions between patients and their healthcare providers."
The allegations were brought to the attention of the department by Lazaro Suarez, who was employed as an AbbVie Nurse Ambassador in Florida.
According to the lawsuit, private insurers have paid out $1.2 billion in pharmacy claims for Humira, which would make the case the largest instance of insurance fraud in the history of the California regulator.